ADVERTISEMENT
A pink graphic of an anatomical heart
The Promise of RNAi Therapeutics for Cardiovascular Disease Treatment
Kevin Fitzgerald from Alnylam Pharmaceuticals explains the potential of RNA interference for treating disease and highlights recent clinical trial successes.
The Promise of RNAi Therapeutics for Cardiovascular Disease Treatment
The Promise of RNAi Therapeutics for Cardiovascular Disease Treatment

Kevin Fitzgerald from Alnylam Pharmaceuticals explains the potential of RNA interference for treating disease and highlights recent clinical trial successes.

Kevin Fitzgerald from Alnylam Pharmaceuticals explains the potential of RNA interference for treating disease and highlights recent clinical trial successes.

clinical trials

iStock
Turning up the Heat on Brain Tumors
Aparna Nathan, PhD | Jul 17, 2023 | 3 min read
Oncolytic viruses can help glioblastoma respond to immunotherapy.
Semi-circle of colorful cancer awareness ribbons
Electric Fields Disrupt Cancer Cell Division
Danielle Gerhard, PhD | May 4, 2023 | 5 min read
A novel, non-invasive treatment using electrical currents exploits physiological properties of dividing cancer cells to prolong survival and augment current therapies.
A photo of Rose Kidd, the president of Global Operations Delivery at ICON.
Advancing Clinical Research Through Effective Data Delivery
The Scientist and ICON | 3 min read
Novel data collection and delivery strategies help usher the clinical research industry into its next era.
Image of a white cardboard box with a blue vertical stripe on the left side, the word “Apixaban” in blue lettering at the bottom, and a depiction of apixaban’s molecular structure in black.
Blood Thinner Ineffective for COVID-19 Patients: Study
Dan Robitzski | Nov 28, 2022 | 2 min read
A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.
a person fumigates a red brick pathway to control mosquitoes in the fight against Dengue virus.
European Medicines Agency Recommends Approving Takeda’s Dengue Vaccine
Katherine Irving | Oct 14, 2022 | 2 min read
In clinical trials, the new inoculation demonstrated greater protection for children and people older than 45 than the existing dengue vaccine.
Precision Medicine-Based Biomarkers for Traumatic Brain Injury
Precision Medicine-Based Biomarkers for Traumatic Brain Injury 
The Scientist | 1 min read
In this webinar, Dr. Kevin Wang will discuss a precision medicine approach for treating traumatic brain injury which uses phenotype biomarkers to monitor disease course and develop novel therapies.
A person in a white shirt activates a nasal spray
Oxford-AstraZeneca Nasal COVID-19 Vaccine Falters in Clinical Trial
Dan Robitzski | Oct 11, 2022 | 2 min read
Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2.
A black and white photo of a woman in a plumed hat in a laboratory classroom with several men
Birth of The Pill, 1956–1960
Andy Carstens | Oct 3, 2022 | 2 min read
Researchers overseeing the clinical trial for the first FDA-approved oral contraceptive claimed the drug gave the Puerto Rican participants power over their family planning. Critics claimed the women were exploited.
A Patient-First Approach to Clinical Trial Enrollment
A Patient-First Approach to Clinical Trial Enrollment
The Scientist | 2 min read
Discover how eConsent forms for clinical trial enrollment are the best path forward for patients, sites, and sponsors.
Illustration of light blue neurons with white amyloid plaques accumulating on their axons.
New Alzheimer’s Drug Slows Cognitive Decline in Clinical Trial
Dan Robitzski | Sep 28, 2022 | 2 min read
The Biogen-developed treatment, called lecanemab, appears to have a more clear-cut effect on slowing the disease than the company’s previous Alzheimer’s drug, Aduhelm.
A wrecking ball destroying a malignant cell as a 3D illustration
Armored CAR T Cells Break Through Immune Suppression in Solid Tumors
Jennifer Zieba, PhD | Sep 26, 2022 | 3 min read
Researchers determined the safety and antitumor ability of genetically engineered CAR T cells that circumvent immune suppression in a prostate cancer phase I clinical trial.
A doctor holding a stethoscope, surrounded by medical icons
Real World Data: Opening New Avenues for Health Research
Liliana Garcia Mondragon, PhD | 4 min read
Scientists and clinicians increasingly use real world data (RWD) to make valuable discoveries that can be applied to the healthcare industry.
Woman holding a glass of water in one hand and pill in the other
Daily Multivitamin May Slow Cognitive Decline in Seniors
Andy Carstens | Sep 14, 2022 | 2 min read
Researchers caution that it’s too soon to recommend supplements based on the results of a new study.
A 3D rendering of a neuron
Independent FDA Advisory Panel Recommends Approving ALS Drug
Amanda Heidt | Sep 8, 2022 | 4 min read
The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient.
Learn about the latest research on optimal vaccine-induced immune responses
Modulating the Immune Response to Vaccines
The Scientist | 1 min read
Researchers uncover innovative natural approaches to fine-tune immunity from vaccination.
A red sign that reads “Clinical Center, Building 10” outside of a brick building
NIH Fails to Enforce Rules for Reporting Clinical Trial Results
Amanda Heidt | Aug 18, 2022 | 3 min read
A review by the US Office of Inspector General found that only about half of the scientists running clinical trials funded by the NIH in 2019 and 2020 appropriately recorded their findings in a federal database, as is legally required.
Photograph of Humsa Venkatesh
Humsa Venkatesh Probes Cancer’s Grip on the Brain
Maddie Bender | Aug 15, 2022 | 3 min read
At Brigham and Women’s Hospital, the cancer biologist is combining research into the tumor microenvironment with the principles of neuroscience to tease apart how cancers grow—and how to stop them.
The Scientist's LabTalk - Episode 4
The Scientist | 1 min read
The Past, Present, and Future of Gene Therapy: How to Scale-up Successfully
Building with sign reading “Novartis”
Two Children Die After Receiving Novartis Gene Therapy
Andy Carstens | Aug 12, 2022 | 1 min read
No deaths had previously been associated with the muscle-wasting treatment Zolgensma.
ADVERTISEMENT